NCT04507074 is a NA clinical trial of lumbar traction therapy in Low Back Pain, sponsored by Poznan University of Physical Education.

Who is sponsoring NCT04507074?

NCT04507074 is sponsored by Poznan University of Physical Education.

What drugs are being tested in NCT04507074?

Interventions in NCT04507074: lumbar traction therapy.

What condition does NCT04507074 study?

NCT04507074 studies Low Back Pain, Obesity.

Is NCT04507074 still recruiting?

NCT04507074 is currently completed. Last updated 23 September 2025.

Last reviewed 2025-09-23 · How we verify

NCT04507074

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Traction Forces in People With Obesity Suffering From Chronic Low Back Pain

Completed NA Last updated 23 September 2025

What this trial tests

NA trial testing lumbar traction therapy in Low Back Pain in 49 participants. Completed in 30 December 2024.

Timeline

1 September 2020

Primary endpoint
31 December 2022

30 December 2024

Quick facts

Lead sponsor	Poznan University of Physical Education
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	49
Start date	1 September 2020
Primary completion	31 December 2022
Estimated completion	30 December 2024
Sites	1 location across Poland

Drugs / interventions tested

lumbar traction therapy

Conditions studied

Low Back Pain — all drugs for Low Back Pain →
Obesity — all drugs for Obesity →

Sponsor

Poznan University of Physical Education

Who can join

Adults 35 to 60, any sex, with Low Back Pain or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the research study is to assess the impact of traction forces on changes in systemic markers concentrations of spinal structure damage in people with obesity. The research group will include 40 subjects aged 35-60 with simple obesity (BMI ≥ 30 kg / m2) and chronic lumbar spine pain syndrome. The control group will consist of 20 subjects with normal body weight suffering from the same pain, at a similar age to the patients in the study group. Persons will be qualified for examination by a specialist in internal medicine and a physiotherapist. To assess the degree of structural damage within the intervertebral disc and adjacent anatomical structures, patients will undergo magnetic resonance imaging of the lumbosacral spine (MRI 1.5T, standard in 3 projections). Patients will undergo traction therapy under the supervision of a physiotherapist. The application of traction forces on the traction table (ST6567P-SEERSMEDICAL) will last 30 minutes a day for 4 weeks (continuous traction mode with a maximum strength of 30% of the patient's body weight). Twice, before and after therapy, the following will be assessed: (1) body composition (by DXA method), (2) other anthropometric indicators, (3) functional parameters of the spine: mobility (electrogoniometer), muscle bioelectric signal amplitude (electromyograph), soft tissue biophysical parameters (myotonometer), (4) pain threshold and intensity in the lumbar region (using an algometer and validated questionnaires), (5) disability caused by pain in the spine (Oswestry questionnaire), (6) blood biochemical indicators selected on the basis of the latest research on biomarkers of spinal damage (for this purpose, 25ml venous blood will be taken from the subjects). Blood levels of interleukin-17, interleukin-4, interleukin-2 (IL-2), interleukin-10 (IL-10), differentiating growth factor 15 (GDF-15), leptin, adipsin, chemokine CCL5 (RANTES), stem cell growth factor β (SCGF-β), vascular endothelial growth factor (VEGF), neuropeptide Y, and chondroitin sulfate CS846 will be determined in the blood of the subjects. It is planned to assess the relationship of the studied biomarkers with the degree of disk degeneration, obesity, lean and fat body mass, pain intensity, and functional indicators of the spine. Patients will be asked to stop taking anti-inflammatory drugs during therapy and at least 24 hours prior to blood sampling.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Subjective assessment and biochemical evaluation of traction therapy in women with chronic low back pain: does body mass index matter? A clinical study.
Ratajczak M, Wendt M, Śliwicka E, Skrypnik D, et al · · 2023 · cited 6× · PMID 36927409 · DOI 10.1186/s12891-023-06300-5
In search of biomarkers for low back pain: can traction therapy effectiveness be prognosed by surface electromyography or blood parameters?
Ratajczak M, Waszak M, Śliwicka E, Wendt M, et al · · 2023 · cited 1× · PMID 38143914 · DOI 10.3389/fphys.2023.1290409
Bone remodelling after application of traction forces to the lumbar spine in women with chronic low back pain.
Ratajczak M, Kusy K, Skrypnik D, Waszak M, et al · · 2025 · PMID 40754314 · DOI 10.1302/2046-3758.148.bjr-2024-0465.r1

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

NCT07526012 — Comparative Effects Of Post Isometric Relaxation Versus Active Isolated Stretch In Patients With Piriformis Syndrome · NA · recruiting
NCT07535047 — Placebo-Induced Hypoalgesia During Transcutaneous Electrical Nerve Stimulation Application in Low Back Pain · NA · recruiting
NCT07463729 — Evaluation of Stabilization Training With Biofeedback in Lumbosacral Spine Pain Syndrome · NA · recruiting
NCT07250568 — Office Program Effects on Pain, Posture, Muscle Physiology, Stress, Ergonomics, and Quality of Life in LBP Workers · NA · recruiting
NCT07467070 — Effectiveness of Pilates on Postural Correction, Core Strength and Flexibility in Younger Individuals With Non-specific · NA · recruiting

Other Poznan University of Physical Education trials

Trials by the same sponsor.

NCT07437833 — Psychophysiological Responses to Six Single-Session Self-Regulation Interventions in a Female Adult With ADHD and Stabil · NA · not yet recruiting
NCT07379606 — Effects of Moderate Exercise and Cyclic Sighing on Stress, Cognition and Physiological Markers in Young Adults · NA · not yet recruiting
NCT07232836 — Cytokines, Neuroplasticity Modulators, and Biomarkers in Spinal Canal Stenosis and Endoscopic Decompression · NA · not yet recruiting
NCT06935058 — Effectiveness of Chocolate Milk in Recovery Among Highly Trained Kayakers: A Metabolic and Inflammatory Perspectives · NA · completed
NCT06926257 — Effects of VR-based Respiratory Training on Motor Reaction Time and Correctness, Stress Levels, Attention, Motor Skills, · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04507074 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Poznan University of Physical Education
Last refreshed: 23 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04507074.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing